文献速递糖尿病

新发糖尿病与长期糖尿病中胰腺癌风险的差异:一项基于人群的队列研究

Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该研究利用韩国国民健康保险服务-国民样本队列2002至2013年数据,对88,396例糖尿病患者按1:1倾向评分匹配非糖尿病对照,采用多因素时间依赖性Cox回归分析。结果显示糖尿病组胰腺癌发病率高于非糖尿病组(0.52% vs 0.16%;P < .001),新发糖尿病组胰腺癌风险高于长期糖尿病组(HR: 1.55;P = .020)。

要点

  • 糖尿病组胰腺癌发病率高于非糖尿病组(0.52% vs 0.16%;P < .001)。
  • 新发糖尿病组胰腺癌风险高于长期糖尿病组(HR: 1.55;P = .020)。
  • 新发糖尿病男性(HR=4.42;95%CI 3.15-6.19)及50余岁患者(HR=7.54;95%CI 3.24-17.56)胰腺癌风险更高。

核心结论

  • 糖尿病患者胰腺癌风险高于非糖尿病 population。
  • 在糖尿病患者中,新发糖尿病比长期糖尿病具有更高的胰腺癌风险。

研究设计与样本

  • 基于韩国国民健康保险服务-国民样本队列2002至2013年数据的基于人群的队列研究。
  • 纳入88,396例糖尿病患者为病例组,按1:1倾向评分匹配选择匹配的非糖尿病 population 为对照组。
  • 采用多因素时间依赖性Cox回归分析探究糖尿病与区分新发和长期糖尿病的时间变量之间的交互作用。

主要发现

  • 糖尿病组胰腺癌发病率高于非糖尿病组(0.52% vs 0.16%;P < .001)。
  • 新发糖尿病组胰腺癌风险HR为3.81(95%CI 2.97-4.88;P < .001);长期糖尿病组HR为1.53(95%CI 1.11-2.11;P < .001)。
  • 新发糖尿病组与长期糖尿病组比较,新发糖尿病组胰腺癌风险更高(HR: 1.55;P = .020)。
  • 亚组分析中新发糖尿病组男性(HR=4.42;95%CI 3.15-6.19;P < .001)和50余岁患者(HR=7.54;95%CI 3.24-17.56;P < .001)分别较匹配的同性别或同年龄对照组(非糖尿病 population)胰腺癌风险更高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Considering the absence of methods to find pancreatic cancer early, surveillance of high-risk groups is needed for early diagnosis. OBJECTIVE: The study aimed to investigate the effect in the incidence of pancreatic cancer and the differences between new-onset diabetes mellitus (NODM) and long-standing DM (LSDM) since NODM group is a representative high-risk group. METHODS: The Korean National Health Insurance Service-National Sample Cohort between 2002 and 2013 data were used. Regarding 88 396 people with DM (case group), we conducted a 1:1 propensity score matching to select a matched non-DM population (control group). To investigate the interaction between DM and the time variable distinguishing NODM and LSDM, we performed a multivariate time-dependent Cox regression analysis. RESULTS: The incidence of pancreatic cancer was higher in the DM group compared to the non-DM group (0.52% vs 0.16%; P < .001). The DM group had shown different risk of pancreatic cancer development according to the duration since the DM diagnosis (NODM hazard ratio (HR): 3.81; 95% CI, 2.97-4.88; P < .001; LSDM HR: 1.53; 95% CI, 1.11-2.11; P < .001). When the NODM and the LSDM groups were compared, the risk of pancreatic cancer was higher in the NODM group than in the LSDM group (HR: 1.55; P = .020). In subgroup analysis, NODM group showed that men (HR = 4.42; 95% CI, 3.15-6.19; P < .001) and patients who were in their 50 seconds (HR = 7.54; 95% CI, 3.24-17.56; P < .001) were at a higher risk of developing pancreatic cancer than matched same sex or age control group (non-DM population), respectively. CONCLUSION: The risk of pancreatic cancer was greater in people with DM than in a non-DM population. Among people with DM, NODM showed a higher risk of pancreatic cancer than LSDM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lee HS, Chae W, Sung MJ, et al. Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study. J Clin Endocrinol Metab. 2023. PMID: 36548964. doi:10.1210/clinem/dgac728

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。